Citadel Advisors
MAIA icon

Citadel Advisors’s MAIA Biotechnology MAIA Stock Holding History

Citadel Advisors’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Buy
+24,890
New +$33.1K ﹤0.01% 13258
2024
Q2 		– Sell
-23,749
Closed -$52.2K – 14956
2024
Q1 		$52.2K Sell
23,749
-33,724
-59% -$50.6K ﹤0.01% 12138
2023
Q4 		$67.2K Buy
+57,473
New +$92.8K ﹤0.01% 11437
2023
Q3 		– Sell
-23,387
Closed -$51.5K – 14757
2023
Q2 		$51.5K Buy
+23,387
New +$62.6K ﹤0.01% 11765

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's MAIA Position: Q2 2026 in Review

Citadel Advisors opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 24,890 shares worth $35.8K. The stake represents ﹤0.01% of the portfolio and ranks #13258 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in MAIA as recently as Q1 2024.

Citadel Advisors first reported a position in MAIA in Q2 2023 and has held it in 4 quarters since. The position peaked at $67.2K in Q4 2023. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Citadel Advisors held 24,890 shares of MAIA Biotechnology worth $35.8K as of Q2 2026.
  • MAIA Biotechnology was a new Citadel Advisors position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13258 holding.
  • Citadel Advisors first reported a position in MAIA Biotechnology in Q2 2023 and has held it in 4 quarters since.
  • Citadel Advisors's MAIA Biotechnology position peaked at $67.2K in Q4 2023.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.